Welcome to our dedicated page for Linde Plc SEC filings (Ticker: LIN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Struggling to sift through hundreds of pages on cryogenic plant performance, gas pricing formulas, and safety metrics buried in Linde plc’s disclosures? Industrial-gas filings are notoriously dense, and Linde’s global footprint makes each footnote even more complex.
Stock Titan removes that friction. Our AI-powered summaries turn the Linde plc annual report 10-K simplified into a five-minute read, flagging segment margins and energy pass-through clauses. Need the latest numbers? The moment a Linde plc quarterly earnings report 10-Q filing or a Linde plc 8-K material events explained hits EDGAR, you’ll see real-time highlights and red-line changes. Monitor Linde plc Form 4 insider transactions real-time to catch engineering executives’ trades, or dive deeper with our Linde plc earnings report filing analysis that links plant utilization trends to cash flow.
Every filing type is covered:
- 10-K – long-term supply contract terms and regional pricing grids
- 10-Q – quarterly tonnage gas volumes with AI variance commentary
- 8-K – new hydrogen hub announcements within hours
- Form 4 – Linde plc insider trading Form 4 transactions plus alerts on Linde plc executive stock transactions Form 4
- DEF 14A – Linde plc proxy statement executive compensation mapped to safety KPIs
Whether you’re understanding Linde plc SEC documents with AI for strategic planning or simply want Linde plc SEC filings explained simply, Stock Titan delivers concise, expert insights so you can act faster with confidence.
Stephen F. Angel, a director of Linde plc (LIN), reported a change in beneficial ownership on Form 4. The filing shows a disposition on 08/18/2025 of 25,000 ordinary shares reported as a charitable gift with no market transaction and a $0 price. After the reported transaction the reporting person holds 455,542.502 ordinary shares directly and additional indirect holdings through trusts and a 401(k), including 71,029 shares via a 2010 Descendants Trust and other indirect interests. The filing also lists multiple outstanding restricted stock units and stock options with specified grant/expiration dates and share amounts.
Enders Thomas, a director of Linde plc (LIN), reported transactions dated 08/18/2025. The filing shows a gift of 2,500 ordinary shares (transaction code G) at a reported price of $0, leaving 10,594.803 ordinary shares beneficially owned following the transfer. The form also reports 467.02 restricted stock units (RSUs) that convert one-for-one into ordinary shares; those RSUs vest in full and pay out in shares one year after the March 7, 2025 grant date, subject to continuous board service with limited pro-rata exceptions. The Form 4 was signed by attorney-in-fact Anthony M. Pepper on 08/19/2025.
Linde plc (LIN) director Stephen F. Angel reported option exercise and share sales on 08/07/2025. The filing shows the acquisition of 125,000 ordinary shares via exercise and contemporaneous dispositions of 74,691 and 50,309 shares at weighted average sale prices reported as $474.94 and $473.38, respectively. The exercise price reported for the transactions is $118.71. The Form 4 lists aggregate post-transaction beneficial ownership totals shown as 605,542.502 shares (direct) and additional indirect holdings held in descendants' trusts, a 401(k) account and deferred share units. The filing is signed by an attorney-in-fact on 08/08/2025.
Linde plc (LIN) Form 144 reports a proposed sale of up to 50,309 ordinary shares, equal to roughly 0.01 % of the 468.9 million shares outstanding. The shares carry an aggregate market value of $23.8 million, implying a price near $473 per share. They were acquired on 08-07-2025 via stock-option exercise and may be sold on or after the same date through Fidelity Brokerage Services on the NASDAQ.
No other sales have occurred in the past three months, and the filer affirms possession of no undisclosed adverse information. Form 144 is a notice, not a commitment to sell; actual sales may differ in timing or size. Given the small fraction of equity involved and absence of operational disclosures, the filing is viewed as routine with limited market impact.
FAQ
What is the current stock price of Linde Plc (LIN)?
What is the market cap of Linde Plc (LIN)?
